Azopt (Brinzolamide) - Indications and Dosage

INDICATIONS AND USAGE

AZOPT® (brinzolamide ophthalmic suspension) 1% is a carbonic anhydrase inhibitor indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.

DOSAGE AND ADMINISTRATION

The recommended dose is 1 drop of AZOPT® (brinzolamide ophthalmic suspension) 1% in the affected eye(s) three times daily. If more than one topical ophthalmic drug is being used, the drugs should be administered at least ten (10) minutes apart.

DOSAGE FORMS AND STRENGTHS

Solution containing 10 mg/mL brinzolamide.

HOW SUPPLIED/STORAGE AND HANDLING

AZOPT® (brinzolamide ophthalmic suspension) 1% is supplied in plastic DROP-TAINER® dispensers with a controlled dispensing-tip as follows:

10 mL NDC 0065-0275-10
15 mL NDC 0065-0275-15

Storage and Handling
Store AZOPT® (brinzolamide ophthalmic suspension) 1% at 4-30°C (39-86°F). Shake well before use.